Showing results (391-400 of 410) with videos related to

Sort By:
Pageof 41
Nature Cancer|February 5, 2022
Astrocytic laminin-211 drives disseminated breast tumor cell dormancy in brainJinxiang Dai, Patrick J Cimino, Kenneth H Gouin, et al.
Scientific Reports|June 28, 2019
Mycobacterium tuberculosis whole genome sequencing provides insights into the Manila strain and drug-resistance mutations in the PhilippinesJody E Phelan, Dodge R Lim, Satoshi Mitarai, et al.
Diabetes|November 8, 2013
A critical role for thioredoxin-interacting protein in diabetes-related impairment of angiogenesisLouise L Dunn, Philippa J L Simpson, Hamish C Prosser, et al.
Molecular Cancer Therapeutics|April 28, 2025
PF-08046032: A novel, investigational CD25-directed antibody-drug conjugate optimized for selective depletion of regulatory T cells in advanced malignant tumorsSherif Abdelhamed, Xinqun Zhang, Weiping Zeng, et al.
European Urology Oncology|March 20, 2026
Enzalutamide Plus Metformin Versus Enzalutamide Alone in Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 2 Trial (SAKK 08/14)S Gillessen, K Gobat, R Cathomas, et al.
Antimicrobial Agents and Chemotherapy|October 1, 2008
Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)Scott D Seiwert, Steven W Andrews, Yutong Jiang, et al.
Spine|May 11, 2006
Reliability of a novel classification system for thoracolumbar injuries: the Thoracolumbar Injury Severity ScoreAlexander R Vaccaro, Eli M Baron, James Sanfilippo, et al.
Cancers|April 3, 2021
Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell CarcinomaEileen Shiuan, Anupama Reddy, Stephanie O Dudzinski, et al.
Scientific Reports|August 23, 2024
Whole genome sequencing analysis of Mycobacterium tuberculosis reveals circulating strain types and drug-resistance mutations in the PhilippinesLinfeng Wang, Dodge R Lim, Jody E Phelan, et al.
Chemistry & Biology|November 12, 2013
PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease modelsDavid G Winkler, Kerrie L Faia, Jonathan P DiNitto, et al.
Pageof 41